News Achieve Life Sciences, Inc.

Equities

ACHV

US0044685008

Delayed Nasdaq Other stock markets 01:22:14 2024-04-25 pm EDT			5-day change	1st Jan Change
4.63 ^USD	+1.98%		+1.31%	+12.38%

Apr. 17	JonesTrading Starts Achieve Life Sciences With Buy Rating, $20 Price Target	MT
Mar. 28	Transcript : Achieve Life Sciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024	08:02am	AQ
JonesTrading Starts Achieve Life Sciences With Buy Rating, $20 Price Target	Apr. 17	MT
Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference	Apr. 11	AQ
Transcript : Achieve Life Sciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024	Mar. 28
Achieve Life Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update	Mar. 28	AQ
Achieve Life Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 28	CI
Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting	Mar. 20	AQ
Achieve Life Sciences, Inc. Announces Data from Cytisinicline ORCA Program to Be Presented at the 2024 Society for Research on Nicotine and Tobacco Annual Meeting	Mar. 20	CI
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024	Mar. 14	AQ
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences	Mar. 06	AQ
Sector Update: Health Care Stocks Decline Late Afternoon	Feb. 29	MT
Sector Update: Health Care	Feb. 29	MT
Achieve Life Sciences Agrees on Safety Exposure Data for Smoking Cessation Medication as Part of NDA	Feb. 29	MT
Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission	Feb. 29	AQ
Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement	Feb. 29	AQ
Top Midday Decliners	Dec. 12	MT
Wall Street Set to Open Slightly Higher Tuesday; Annual Inflation Declines to 3.1%	Dec. 12	MT
Oppenheimer Adjusts Achieve Life Sciences Price Target to $18 From $21, Maintains Outperform Rating	Dec. 12	MT
Investors Await Inflation Data, Look to Last Fed Meeting of Year as US Futures Rise Slightly in Tuesday's Premarket	Dec. 12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Achieve Life Sciences, Inc.

Equities

ACHV

US0044685008

Summary

Filters